RASolute 302

Event

Phase 3 clinical trial evaluating daraxonrasib vs. chemotherapy in previously treated metastatic pancreatic cancer

6 stories

Global Clinical Trial Reports Major Breakthrough in Pancreatic Cancer Treatment

Pancreatic Cancer Patients Face Significant Barriers Accessing Promising New Drug

Landmark Trial Reports Breakthrough Against Cancers Previously Deemed 'Undruggable'

Pancreatic Cancer Drug Doubles Patient Survival Time in Landmark Trial

Daily Pill Shown to Double Survival Time for Highly Lethal Cancer in Clinical Trial

FDA Grants Early Access to Experimental Pancreatic Cancer Drug